• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PPAR 与 RXR 伴侣之间的串扰:分子视角。

Cross-Talk between PPARs and the Partners of RXR: A Molecular Perspective.

机构信息

Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada M5G 2M9.

出版信息

PPAR Res. 2009;2009:925309. doi: 10.1155/2009/925309. Epub 2009 Dec 20.

DOI:10.1155/2009/925309
PMID:20052392
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2801013/
Abstract

The PPARs are integral parts of the RXR-dependent signaling networks. Many other nuclear receptor subfamily 1 members also require RXR as their obligatory heterodimerization partner and they are often co-expressed in any given tissue. Therefore, the PPARs often complete with other RXR-dependent nuclear receptors and this competition has important biological implications. Thorough understanding of this cross-talk at the molecular level is crucial to determine the detailed functional roles of the PPARs. At the level of DNA binding, most RXR heterodimers bind selectively to the well-known "DR1 to 5" DNA response elements. As a result, many heterodimers share the same DR element and must complete with each other for DNA binding. At the level of heterodimerization, the partners of RXR share the same RXR dimerization interface. As a result, individual nuclear receptors must complete with each other for RXR to form functional heterodimers. Cross-talk through DNA binding and RXR heterodimerization present challenges to the study of these nuclear receptors that cannot be adequately addressed by current experimental approaches. Novel tools, such as engineered nuclear receptors with altered dimerization properties, are currently being developed. These tools will enable future studies to dissect specific RXR heterodimers and their signaling pathways.

摘要

PPAR 是 RXR 依赖性信号网络的组成部分。许多其他核受体亚家族 1 成员也需要 RXR 作为其必需的异二聚体化伙伴,并且它们通常在任何给定的组织中共同表达。因此,PPAR 通常与其他 RXR 依赖性核受体竞争,这种竞争具有重要的生物学意义。在分子水平上彻底理解这种串扰对于确定 PPAR 的详细功能作用至关重要。在 DNA 结合水平上,大多数 RXR 异二聚体选择性地结合到众所周知的“DR1 到 5”DNA 反应元件。因此,许多异二聚体共享相同的 DR 元件,必须相互竞争以进行 DNA 结合。在异二聚化水平上,RXR 的伴侣共享相同的 RXR 二聚化界面。因此,单个核受体必须相互竞争以形成功能性异二聚体。通过 DNA 结合和 RXR 异二聚化的串扰给这些核受体的研究带来了挑战,当前的实验方法无法充分解决这些挑战。目前正在开发具有改变的二聚化特性的工程核受体等新型工具。这些工具将使未来的研究能够剖析特定的 RXR 异二聚体及其信号通路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/2801013/1d0eab8185c1/PPAR2009-925309.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/2801013/60a2af72624c/PPAR2009-925309.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/2801013/b77b7f03bc11/PPAR2009-925309.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/2801013/ff60a8cec7e8/PPAR2009-925309.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/2801013/1d0eab8185c1/PPAR2009-925309.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/2801013/60a2af72624c/PPAR2009-925309.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/2801013/b77b7f03bc11/PPAR2009-925309.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/2801013/ff60a8cec7e8/PPAR2009-925309.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/2801013/1d0eab8185c1/PPAR2009-925309.004.jpg

相似文献

1
Cross-Talk between PPARs and the Partners of RXR: A Molecular Perspective.PPAR 与 RXR 伴侣之间的串扰:分子视角。
PPAR Res. 2009;2009:925309. doi: 10.1155/2009/925309. Epub 2009 Dec 20.
2
Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors.过氧化物酶体增殖物激活受体和视黄酸受体以不同方式控制类视黄醇X受体异二聚体与配体、共激活因子和共抑制因子的相互作用。
Mol Cell Biol. 1997 Apr;17(4):2166-76. doi: 10.1128/MCB.17.4.2166.
3
Conserved amino acids in the ligand-binding and tau(i) domains of the peroxisome proliferator-activated receptor alpha are necessary for heterodimerization with RXR.过氧化物酶体增殖物激活受体α的配体结合域和tau(i)结构域中的保守氨基酸对于与视黄醇X受体的异源二聚化是必需的。
Mol Cell Endocrinol. 1999 Jan 25;147(1-2):37-47. doi: 10.1016/s0303-7207(98)00217-2.
4
Defining requirements for heterodimerization between the retinoid X receptor and the orphan nuclear receptor Nurr1.确定视黄酸X受体与孤儿核受体Nurr1之间异源二聚化的要求。
J Biol Chem. 2002 Sep 20;277(38):35118-23. doi: 10.1074/jbc.M201707200. Epub 2002 Jul 18.
5
Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat.过氧化物酶体增殖物激活受体通过与维甲酸X受体竞争介导与甲状腺激素受体的相互作用。亮氨酸拉链样七肽重复序列的可能作用。
J Biol Chem. 1995 Jul 28;270(30):18117-22. doi: 10.1074/jbc.270.30.18117.
6
Separation of retinoid X receptor homo- and heterodimerization functions.维甲酸X受体同源和异源二聚化功能的分离
Mol Cell Biol. 2003 Nov;23(21):7678-88. doi: 10.1128/MCB.23.21.7678-7688.2003.
7
Ligand- and DNA-induced dissociation of RXR tetramers.配体和DNA诱导的视黄酸X受体四聚体解离
J Mol Biol. 1998 Jan 9;275(1):55-65. doi: 10.1006/jmbi.1997.1413.
8
Protein-protein interaction domains and the heterodimerization of thyroid hormone receptor variant alpha2 with retinoid X receptors.蛋白质-蛋白质相互作用结构域以及甲状腺激素受体变体α2与视黄酸X受体的异源二聚化
Mol Endocrinol. 1998 Oct;12(10):1542-50. doi: 10.1210/mend.12.10.0178.
9
A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding.锌指结构域的羧基末端延伸对过氧化物酶体增殖物激活受体DNA结合的特异性和极性有贡献。
J Biol Chem. 1998 Oct 23;273(43):27988-97. doi: 10.1074/jbc.273.43.27988.
10
A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1.一种由视黄醇X受体(RXR)与NGFI-B和NURR1异源二聚化介导的维生素A信号传导新途径。
Genes Dev. 1995 Apr 1;9(7):769-82. doi: 10.1101/gad.9.7.769.

引用本文的文献

1
Effect of retinoic acid treatment on the retinoic acid signaling pathway in a human siRNA-based aniridia limbal epithelial cell model, in vitro.视黄酸处理对体外人源基于小干扰RNA的无虹膜角膜缘上皮细胞模型中视黄酸信号通路的影响。
PLoS One. 2025 Jun 18;20(6):e0324946. doi: 10.1371/journal.pone.0324946. eCollection 2025.
2
LncRNA Gm35585 transcriptionally activates the peroxidase EHHADH against diet-induced fatty liver.长链非编码RNA Gm35585通过转录激活过氧化物酶EHHADH来对抗饮食诱导的脂肪肝。
Exp Mol Med. 2025 Mar;57(3):652-666. doi: 10.1038/s12276-025-01420-5. Epub 2025 Mar 13.
3
The Endocannabinoid System: Implications in Gastrointestinal Physiology and Pathology.

本文引用的文献

1
Developmental expression of retinoic acid receptors (RARs).维甲酸受体(RARs)的发育表达
Nucl Recept Signal. 2009 May 12;7:e006. doi: 10.1621/nrs.07006.
2
Minireview: Evolution of NURSA, the Nuclear Receptor Signaling Atlas.小型综述:核受体信号图谱NURSA的发展历程
Mol Endocrinol. 2009 Jun;23(6):740-6. doi: 10.1210/me.2009-0135. Epub 2009 May 7.
3
Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA.完整的PPAR-γ-RXR核受体复合物在DNA上的结构。
内源性大麻素系统:对胃肠生理学和病理学的影响
Int J Mol Sci. 2025 Feb 3;26(3):1306. doi: 10.3390/ijms26031306.
4
Surprising features of nuclear receptor interaction networks revealed by live-cell single-molecule imaging.活细胞单分子成像揭示核受体相互作用网络的惊人特征。
Elife. 2025 Jan 10;12:RP92979. doi: 10.7554/eLife.92979.
5
DT-13 Mediates Ligand-Dependent Activation of PPARγ Response Elements In Vitro.DT-13在体外介导过氧化物酶体增殖物激活受体γ反应元件的配体依赖性激活。
Biology (Basel). 2024 Dec 4;13(12):1015. doi: 10.3390/biology13121015.
6
Circulating Interleukin-6 Mediates PM-Induced Ovarian Injury by Suppressing the PPARγ Pathway.循环白细胞介素-6通过抑制PPARγ通路介导颗粒物诱导的卵巢损伤。
Research (Wash D C). 2024 Dec 5;7:0538. doi: 10.34133/research.0538. eCollection 2024.
7
Identification of Novel PPARγ Partial Agonists Based on Virtual Screening Strategy: In Silico and In Vitro Experimental Validation.基于虚拟筛选策略的新型 PPARγ 部分激动剂的鉴定:计算机模拟和体外实验验证。
Molecules. 2024 Oct 15;29(20):4881. doi: 10.3390/molecules29204881.
8
Modern-Day Therapeutics and Ongoing Clinical Trials against Type 2 Diabetes Mellitus: A Narrative Review.现代治疗方法与2型糖尿病的正在进行的临床试验:一项叙述性综述
Curr Diabetes Rev. 2025;21(6):59-74. doi: 10.2174/0115733998294919240506044544.
9
Surprising Features of Nuclear Receptor Interaction Networks Revealed by Live Cell Single Molecule Imaging.活细胞单分子成像揭示核受体相互作用网络的惊人特征
bioRxiv. 2024 Oct 30:2023.09.16.558083. doi: 10.1101/2023.09.16.558083.
10
RXR Agonists Enhance Lenalidomide Anti-Myeloma Activity and T Cell Functions while Retaining Glucose-Lowering Effect.RXR 激动剂增强来那度胺的抗骨髓瘤活性和 T 细胞功能,同时保留降血糖作用。
Cells. 2023 Aug 3;12(15):1993. doi: 10.3390/cells12151993.
Nature. 2008 Nov 20;456(7220):350-6. doi: 10.1038/nature07413.
4
Manipulation of reciprocal salt bridges at the heterodimerization interface alters the dimerization properties of mouse RXRalpha and PPARgamma1.对异源二聚化界面处的相互盐桥进行操作会改变小鼠视黄酸X受体α(RXRα)和过氧化物酶体增殖物激活受体γ1(PPARγ1)的二聚化特性。
Biochem Biophys Res Commun. 2007 Jul 13;358(4):1080-5. doi: 10.1016/j.bbrc.2007.05.051. Epub 2007 May 22.
5
PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma.前列腺癌和膀胱癌中不依赖过氧化物酶体增殖物激活受体γ的生长停滞和凋亡诱导
BMC Cancer. 2006 Mar 6;6:53. doi: 10.1186/1471-2407-6-53.
6
Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1alpha gene transcription: an autoregulatory loop controls PGC-1alpha expression in adipocytes via peroxisome proliferator-activated receptor-gamma coactivation.噻唑烷二酮类药物和视黄酸X受体激动剂诱导过氧化物酶体增殖物激活受体辅激活因子(PGC)-1α基因转录:一种自调节环通过过氧化物酶体增殖物激活受体γ共激活作用控制脂肪细胞中PGC-1α的表达。
Endocrinology. 2006 Jun;147(6):2829-38. doi: 10.1210/en.2006-0070. Epub 2006 Mar 2.
7
Peroxisome proliferator-activated receptor gamma-independent repression of prostate-specific antigen expression by thiazolidinediones in prostate cancer cells.噻唑烷二酮类药物在前列腺癌细胞中对前列腺特异性抗原表达的过氧化物酶体增殖物激活受体γ非依赖性抑制作用
Mol Pharmacol. 2006 May;69(5):1564-70. doi: 10.1124/mol.105.018333. Epub 2006 Feb 1.
8
Nonclassical action of retinoic acid on the activation of the cAMP response element-binding protein in normal human bronchial epithelial cells.视黄酸对正常人支气管上皮细胞中环磷酸腺苷反应元件结合蛋白激活的非经典作用。
Mol Biol Cell. 2006 Feb;17(2):566-75. doi: 10.1091/mbc.e05-06-0519. Epub 2005 Nov 9.
9
Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model.在甲状腺激素抵抗小鼠模型中揭示了甲状腺激素受体与肝脏X受体调节途径之间的相互作用。
J Biol Chem. 2006 Jan 6;281(1):295-302. doi: 10.1074/jbc.M507877200. Epub 2005 Oct 31.
10
Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure.发现取代马来酰亚胺作为肝脏X受体激动剂并测定配体结合晶体结构。
J Med Chem. 2005 Aug 25;48(17):5419-22. doi: 10.1021/jm050532w.